These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9127100)

  • 21. Detection of immunoglobulin G antibodies to Toxoplasma gondii: Evaluation of two commercial immunoassay systems.
    Tekkesin N; Keskin K; Kılınc C; Orgen N; Molo K
    J Microbiol Immunol Infect; 2011 Feb; 44(1):21-6. PubMed ID: 21531348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimation of the avidity of immunoglobulin G for routine diagnosis of chronic Toxoplasma gondii infection in pregnant women.
    Cozon GJ; Ferrandiz J; Nebhi H; Wallon M; Peyron F
    Eur J Clin Microbiol Infect Dis; 1998 Jan; 17(1):32-6. PubMed ID: 9512179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index.
    Petersen E; Borobio MV; Guy E; Liesenfeld O; Meroni V; Naessens A; Spranzi E; Thulliez P
    J Clin Microbiol; 2005 Apr; 43(4):1570-4. PubMed ID: 15814967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the Roche Elecsys Toxo IgG and IgM electrochemiluminescence immunoassay for the detection of gestational Toxoplasma infection.
    Prusa AR; Hayde M; Unterasinger L; Pollak A; Herkner KR; Kasper DC
    Diagn Microbiol Infect Dis; 2010 Dec; 68(4):352-7. PubMed ID: 20884150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of toxoplasma-specific immunoglobulin G in human sera: performance comparison of in house Dot-ELISA with ECLIA and ELISA.
    Teimouri A; Modarressi MH; Shojaee S; Mohebali M; Zouei N; Rezaian M; Keshavarz H
    Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1421-1429. PubMed ID: 29737440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgG avidity assay firms up the diagnosis of acute toxoplasmosis on the first serum sample in immunocompetent pregnant women.
    Candolfi E; Pastor R; Huber R; Filisetti D; Villard O
    Diagn Microbiol Infect Dis; 2007 May; 58(1):83-8. PubMed ID: 17368807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Particle counting assay for anti-toxoplasma IgG antibodies. Comparison with four automated commercial enzyme-linked immunoassays.
    Galanti LM; Dell'Omo J; Wanet B; Guarin JL; Jamart J; Garrino MG; Masson PL; Cambiaso CL
    J Immunol Methods; 1997 Sep; 207(2):195-201. PubMed ID: 9368646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of anti-Toxoplasma gondii immunoglobulin G avidity: adaptation to the Vidas system (bioMérieux).
    Pelloux H; Brun E; Vernet G; Marcillat S; Jolivet M; Guergour D; Fricker-Hidalgo H; Goullier-Fleuret A; Ambroise-Thomas P
    Diagn Microbiol Infect Dis; 1998 Oct; 32(2):69-73. PubMed ID: 9823527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of utility of specific immunoglobulin G antibody avidity for serodiagnosis of reactivated toxoplasmosis in immunocompromised patients.
    Mechain B; Garin YJ; Robert-Gangneux F; Dupouy-Camet J; Derouin F
    Clin Diagn Lab Immunol; 2000 Jul; 7(4):703-5. PubMed ID: 10882677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Avidity of IgG anti-Toxoplasma gondii. Study to establish a new decision tree for screening].
    Pfister P; Dromigny JA
    Arch Inst Pasteur Madagascar; 2001; 67(1-2):57-60. PubMed ID: 12471751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of IgG Avidity test in case definitions of toxoplasmosis in pregnancy.
    Zotti C; Charrier L; Giacomuzzi M; Moiraghi Ruggenini A; Mombrò M; Fabris C; Marocchetti P; Alfieri R; Leto R; Renzi N; Milano R; Lievre MA; Colozza M; Zanella D; Antona G; Paschero MC; Tosetti F; Miglietti D; Nicoletta T; De Renzi G; Tinivella F; Donati M; Ferrini A; Crotti G; Coucourde L; Guazzotti GC; Gera A; Malabaila A; Di Natale C; Rabozzi ML; Ginardi C; Bruzzone T; Canepa C; Fruttero M; Mastracchio G; Valle S; Toppino M; Forno N; Bellingeri P; Caraccio W; Lazzara C; Decaroli V; Pedrazzi E; Gomella S;
    New Microbiol; 2004 Jan; 27(1):17-20. PubMed ID: 14964401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a recombinant rhoptry protein 2 enzyme-linked immunoassay for the diagnosis of toxoplasmosis acquired during pregnancy.
    Capobiango JD; Pagliari S; Pasquali AK; Nino B; Ferreira FP; Monica TC; Tschurtschenthaler NN; Navarro IT; Garcia JL; Mitsuka-Breganó R; Reiche EM
    Mem Inst Oswaldo Cruz; 2015 Sep; 110(6):732-8. PubMed ID: 26517651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Capture immunoassay for the detection of human IgG against Toxoplasma gondii protein P30].
    Moleón I; González T; Machín R; Molina JR; García CA
    Rev Latinoam Microbiol; 1993; 35(3):309-14. PubMed ID: 8047734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A technique for dating toxoplasmosis in pregnancy and comparison with the Vidas anti-toxoplasma IgG avidity test.
    Flori P; Bellete B; Crampe C; Maudry A; Patural H; Chauleur C; Hafid J; Raberin H; Tran Manh Sung R
    Clin Microbiol Infect; 2008 Mar; 14(3):242-9. PubMed ID: 18070124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Toxoplasmosis IgG avidity: what importance does it have in pregnancy?].
    Suter BJ; Blatter S; Bittar M; Viollier EH
    Schweiz Med Wochenschr; 1999 Dec; 129(49):1938-41. PubMed ID: 10635088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of immunoglobulin M antibodies specific for Toxoplasma gondii with increased selectivity for recently acquired infections.
    Kaul R; Chen P; Binder SR
    J Clin Microbiol; 2004 Dec; 42(12):5705-9. PubMed ID: 15583302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevalence of toxoplasma antibodies in pregnant patients attending the Port Moresby General Hospital antenatal clinic: a seroepidemiological survey.
    Klufio CA; Delamare O; Amoa AB; Kariwiga G
    P N G Med J; 1993 Mar; 36(1):4-9. PubMed ID: 8266732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification, production and assessment of two Toxoplasma gondii recombinant proteins for use in a Toxoplasma IgG avidity assay.
    Teh AY; Amerizadeh A; Osman S; Yunus MH; Noordin R
    Pathog Glob Health; 2016; 110(7-8):277-286. PubMed ID: 27697019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antenatal screening for hepatitis B and antibodies to Toxoplasma gondii and rubella virus: evaluation of two commercial immunoassay systems.
    Diepersloot RJ; Dunnewold-Hoekstra H; Kruit-Den Hollander J; Vlaspolder F
    Clin Diagn Lab Immunol; 2001 Jul; 8(4):785-7. PubMed ID: 11427427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct agglutination test and other assays for measuring antibodies to Toxoplasma gondii.
    Johnson J; Duffy K; New L; Holliman RE; Chessum BS; Fleck DG
    J Clin Pathol; 1989 May; 42(5):536-41. PubMed ID: 2732349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.